United Therapeutics falls on quarterly profit miss

Liquidia

26/02/2025 14:16

** Shares of drugmaker United Therapeutics UTHR.O down 3.5% at $345 premarket

** Co posts quarterly adj profit of $6.19 per share, missing analysts' estimates of $6.31 per share, according to data compiled by LSEG

** However, co's Q4 revenue came in at $735.9 million on sales of its lung disorder inhaled-drug Tyvaso, slightly above estimates of $734.7 million

** Brokerage Leerink Partners says it appears that Tyvaso was not quite able to buck seasonal trends this quarter unlike a year ago

** The stock has risen ~60% in the last 12 months

 (Reporting by Siddhi Mahatole)

 ((Siddhiprabhanjan.mahatole@thomsonreuters.com))